Cellular and molecular biology of megakaryocyte differentiation in the absence of lineage-restricted transcription factors
- PMID: 11012181
- DOI: 10.1002/stem.5530160712
Cellular and molecular biology of megakaryocyte differentiation in the absence of lineage-restricted transcription factors
Abstract
Targeted gene disruption of two distinct lineage-restricted hematopoietic transcription factors has provided useful insights into the transcriptional control of platelet production. Absence of either the basic leucine-zipper protein NF-E2 or of the zinc-finger protein GATA-1 in vivo results in severe thrombocytopenia secondary to distinct patterns of arrested megakaryocyte cytoplasmic maturation; in addition, megakaryocyte-selective loss of GATA-1 expression leads to dysregulated proliferation of progenitor cells. The ultrastructure of the defective megakaryocytes suggests that absence of the respective transcription factors impairs biogenesis of platelet-specific granules and proper development and organization of demarcation membranes. In particular, transcriptional targets of NF-E2 may be implicated in the very final stages of megakaryocyte differentiation, which involve the organization and release of platelets. Preliminary characterization of genes that are downregulated in NF-E2-/- megakaryocytes is in progress and is likely to lead to mechanistic insights into thrombocytopoiesis.
Similar articles
-
Molecular and transcriptional regulation of megakaryocyte differentiation.Stem Cells. 2001;19(5):397-407. doi: 10.1634/stemcells.19-5-397. Stem Cells. 2001. PMID: 11553848 Review.
-
Loss of the transcription factor p45 NF-E2 results in a developmental arrest of megakaryocyte differentiation and the onset of a high bone mass phenotype.Bone. 2005 Feb;36(2):215-23. doi: 10.1016/j.bone.2004.09.024. Bone. 2005. PMID: 15780947
-
The role of transcription factor NF-E2 in megakaryocyte maturation and platelet production.Stem Cells. 1996;14 Suppl 1:112-5. doi: 10.1002/stem.5530140714. Stem Cells. 1996. PMID: 11012210 Review.
-
Cyclin D3 and megakaryocyte development: exploration of a transgenic phenotype.Stem Cells. 1998;16 Suppl 2:97-106. doi: 10.1002/stem.5530160713. Stem Cells. 1998. PMID: 11012182
-
A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development.EMBO J. 1997 Jul 1;16(13):3965-73. doi: 10.1093/emboj/16.13.3965. EMBO J. 1997. PMID: 9233806 Free PMC article.
Cited by
-
The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor.Blood. 2007 Feb 15;109(4):1460-71. doi: 10.1182/blood-2006-07-030726. Epub 2006 Oct 12. Blood. 2007. PMID: 17038527 Free PMC article.
-
Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development.Blood. 2005 Aug 15;106(4):1223-31. doi: 10.1182/blood-2005-02-0551. Epub 2005 Apr 28. Blood. 2005. PMID: 15860665 Free PMC article.
-
Dynamin 3 participates in the growth and development of megakaryocytes.Exp Hematol. 2008 Dec;36(12):1714-27. doi: 10.1016/j.exphem.2008.08.010. Exp Hematol. 2008. PMID: 19007685 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources